Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

Nature Cell Biology volume 12, pages 247–256 (2010)Cite this article

Subjects

Abstract

MicroRNAs (miRNAs) are increasingly implicated in regulating the malignant progression of cancer. Here we show that miR-9, which is upregulated in breast cancer cells, directly targets CDH1, the E-cadherin-encoding messenger RNA, leading to increased cell motility and invasiveness. miR-9-mediated E-cadherin downregulation results in the activation of β-catenin signalling, which contributes to upregulated expression of the gene encoding vascular endothelial growth factor (VEGF); this leads, in turn, to increased tumour angiogenesis. Overexpression of miR-9 in otherwise non-metastatic breast tumour cells enables these cells to form pulmonary micrometastases in mice. Conversely, inhibiting miR-9 by using a 'miRNA sponge' in highly malignant cells inhibits metastasis formation. Expression of miR-9 is activated by MYC and MYCN, both of which directly bind to the mir-9-3 locus. Significantly, in human cancers, miR-9 levels correlate with MYCN amplification, tumour grade and metastatic status. These findings uncover a regulatory and signalling pathway involving a metastasis-promoting miRNA that is predicted to directly target expression of the key metastasis-suppressing protein E-cadherin.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: miR-9 directly targets CDH1 and increases cell motility and invasiveness.
Figure 2: miR-9 increases VEGF levels in an E-cadherin-dependent and β-catenin-dependent manner.
Figure 3: miR-9 induces angiogenesis, mesenchymal marker expression and metastasis of the SUM149 epithelial tumours.
Figure 4: Inhibiting miR-9 suppresses metastasis.
Figure 5: miR-9 expression is activated by MYC/MYCN.
Figure 6: miR-9 levels correlate with MYCN amplification and metastatic status in human cancers.

Similar content being viewed by others

References

  1. Fidler, I. J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature Rev. Cancer 3, 453–458 (2003).

    Article  CAS  Google Scholar 

  2. Thiery, J. P. Epithelial–mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442–454 (2002).

    Article  CAS  Google Scholar 

  3. Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. & Calin, G. A. MicroRNAs — the micro steering wheel of tumour metastases. Nature Rev. Cancer 9, 293–302 (2009).

    Article  CAS  Google Scholar 

  4. Ma, L. & Weinberg, R. A. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet. 24, 448–456 (2008).

    Article  CAS  Google Scholar 

  5. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).

    Article  CAS  Google Scholar 

  6. Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682–688 (2007).

    Article  CAS  Google Scholar 

  7. Huang, Q. et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nature Cell Biol. 10, 202–210 (2008).

    Article  CAS  Google Scholar 

  8. Tavazoie, S. F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147–152 (2008).

    Article  CAS  Google Scholar 

  9. Asangani, I. A. et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128–2136 (2008).

    Article  CAS  Google Scholar 

  10. Zhu, S. et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18, 350–359 (2008).

    Article  CAS  Google Scholar 

  11. Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032–1046 (2009).

    Article  CAS  Google Scholar 

  12. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biol. 10, 593–601 (2008).

    Article  CAS  Google Scholar 

  13. Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894–907 (2008).

    Article  CAS  Google Scholar 

  14. Deo, M., Yu, J. Y., Chung, K. H., Tippens, M. & Turner, D. L. Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev. Dyn. 235, 2538–2548 (2006).

    Article  CAS  Google Scholar 

  15. Leucht, C. et al. MicroRNA-9 directs late organizer activity of the midbrain–hindbrain boundary. Nature Neurosci. 11, 641–648 (2008).

    Article  CAS  Google Scholar 

  16. Nass, D. et al. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 19, 375–383 (2009).

    Article  CAS  Google Scholar 

  17. Iorio, M. V. et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065–7070 (2005).

    Article  CAS  Google Scholar 

  18. Sun, Y. et al. Expression profile of microRNAs in c-Myc induced mouse mammary tumors. Breast Cancer Res. Treat. 118, 185–196 (2008).

    Article  Google Scholar 

  19. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20 (2005).

    Article  CAS  Google Scholar 

  20. Krek, A. et al. Combinatorial microRNA target predictions. Nature Genet. 37, 495–500 (2005).

    Article  CAS  Google Scholar 

  21. Gumbiner, B. M. Regulation of cadherin-mediated adhesion in morphogenesis. Nature Rev. Mol. Cell Biol. 6, 622–634 (2005).

    Article  CAS  Google Scholar 

  22. Ceteci, F. et al. Disruption of tumor cell adhesion promotes angiogenic switch and progression to micrometastasis in RAF-driven murine lung cancer. Cancer Cell 12, 145–159 (2007).

    Article  CAS  Google Scholar 

  23. Frixen, U. H. et al. E-cadherin-mediated cell–cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113, 173–185 (1991).

    Article  CAS  Google Scholar 

  24. Vleminckx, K., Vakaet, L. Jr, Mareel, M., Fiers, W. & van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66, 107–119 (1991).

    Article  CAS  Google Scholar 

  25. Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H. & Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190–193 (1998).

    Article  CAS  Google Scholar 

  26. Derksen, P. W. et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10, 437–449 (2006).

    Article  CAS  Google Scholar 

  27. Onder, T. T. et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68, 3645–3654 (2008).

    Article  CAS  Google Scholar 

  28. Elenbaas, B. et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15, 50–65 (2001).

    Article  CAS  Google Scholar 

  29. Ethier, S. P., Mahacek, M. L., Gullick, W. J., Frank, T. S. & Weber, B. L. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res. 53, 627–635 (1993).

    CAS  PubMed  Google Scholar 

  30. Nusse, R. Wnt signaling in disease and in development. Cell Res. 15, 28–32 (2005).

    Article  CAS  Google Scholar 

  31. Wong, A. S. & Gumbiner, B. M. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J. Cell Biol. 161, 1191–1203 (2003).

    Article  CAS  Google Scholar 

  32. Gottardi, C. J., Wong, E. & Gumbiner, B. M. E-cadherin suppresses cellular transformation by inhibiting β-catenin signaling in an adhesion-independent manner. J. Cell Biol. 153, 1049–1060 (2001).

    Article  CAS  Google Scholar 

  33. Veeman, M. T., Slusarski, D. C., Kaykas, A., Louie, S. H. & Moon, R. T. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr. Biol. 13, 680–685 (2003).

    Article  CAS  Google Scholar 

  34. Skurk, C. et al. Glycogen-synthase kinase3β/β-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ. Res. 96, 308–318 (2005).

    Article  CAS  Google Scholar 

  35. Kuperwasser, C. et al. A mouse model of human breast cancer metastasis to human bone. Cancer Res. 65, 6130–6138 (2005).

    Article  CAS  Google Scholar 

  36. Ebert, M. S., Neilson, J. R. & Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nature Methods 4, 721–726 (2007).

    Article  CAS  Google Scholar 

  37. Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005).

    Article  CAS  Google Scholar 

  38. von Lintig, F. C. et al. Ras activation in human breast cancer. Breast Cancer Res. Treat. 62, 51–62 (2000).

    Article  CAS  Google Scholar 

  39. Watnick, R. S., Cheng, Y. N., Rangarajan, A., Ince, T. A. & Weinberg, R. A. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3, 219–231 (2003).

    Article  CAS  Google Scholar 

  40. Rak, J. et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55, 4575–4580 (1995).

    CAS  PubMed  Google Scholar 

  41. Chang, T. C. et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genet. 40, 43–50 (2008).

    Article  CAS  Google Scholar 

  42. Schulte, J. H. et al. MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int. J. Cancer 122, 699–704 (2008).

    Article  CAS  Google Scholar 

  43. O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. & Mendell, J. T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839–843 (2005).

    Article  CAS  Google Scholar 

  44. Malynn, B. A. et al. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 14, 1390–1399 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Fontana, L. et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS ONE 3, e2236 (2008).

    Article  Google Scholar 

  46. Guccione, E. et al. Myc-binding-site recognition in the human genome is determined by chromatin context. Nature Cell Biol. 8, 764–770 (2006).

    Article  CAS  Google Scholar 

  47. Marson, A. et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134, 521–533 (2008).

    Article  CAS  Google Scholar 

  48. Northcott, P. A. et al. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 69, 3249–3255 (2009).

    Article  CAS  Google Scholar 

  49. Lujambio, A. et al. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci. USA 105, 13556–13561 (2008).

    Article  CAS  Google Scholar 

  50. Nesbit, C. E., Tersak, J. M. & Prochownik, E. V. MYC oncogenes and human neoplastic disease. Oncogene 18, 3004–3016 (1999).

    Article  CAS  Google Scholar 

  51. Mani, S. A. et al. The epithelial–mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715 (2008).

    Article  CAS  Google Scholar 

  52. Chen, C. Z., Li, L., Lodish, H. F. & Bartel, D. P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83–86 (2004).

    Article  CAS  Google Scholar 

  53. Cheng, A. M., Byrom, M. W., Shelton, J. & Ford, L. P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33, 1290–1297 (2005).

    Article  CAS  Google Scholar 

  54. Stewart, S. A. et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9, 493–501 (2003).

    Article  CAS  Google Scholar 

  55. Westermann, F. et al. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Genome Biol. 9, R150 (2008).

    Article  Google Scholar 

  56. Mestdagh, P. et al. MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene (in the press) doi: 10.1038/onc.2009.429.

    Article  Google Scholar 

  57. Brodeur, G. M. et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J. Clin. Oncol. 6, 1874–1881 (1988).

    Article  CAS  Google Scholar 

  58. Mestdagh, P. et al. High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res. 36, e143 (2008).

    Article  Google Scholar 

  59. Mestdagh, P. et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 10, R64 (2009).

    Article  Google Scholar 

Download references

Acknowledgements

We thank Johannes Schulte, Martin Eilers, Rosa Noguera, Margaret Ebert and Phillip Sharp for providing tumour samples and reagents; the Histology Core Lab at Massachusetts Institute of Technology (MIT) and Memorial Sloan-Kettering Cancer Center (MSKCC) for assistance with sectioning and immunohistochemistry; and members of the Weinberg laboratory for useful discussions. L.M. is a recipient of a Life Sciences Research Foundation Fellowship, a Margaret and Herman Sokol Award, and a National Institutes of Health (NIH) Pathway to Independence Award (K99/R00). J.Y. and E.P. are supported by a Howard Hughes Medical Institute Undergraduate Fellowship. J.T.-F. is supported by the MSKCC Cancer Core Grant. T.T.O. and S.V. are recipients of a US Department of Defense Breast Cancer Research Program Predoctoral Fellowship. R.A.W. is an American Cancer Society Research Professor and a Daniel K. Ludwig Cancer Research Professor. This research is supported by a NIH grant to R.A.W. and the Ludwig Center for Molecular Oncology at MIT.

Author information

Author notes

  1. Jennifer Young and Harsha Prabhala: These authors contributed equally to this work.

Authors and Affiliations

  1. Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, 02142, Massachusetts, USA

    Li Ma, Jennifer Young, Elizabeth Pan, Ferenc Reinhardt, Tamer T. Onder, Scott Valastyan & Robert A. Weinberg

  2. Massachusetts Institute of Technology Ludwig Center for Molecular Oncology, Cambridge, 02142, Massachusetts, USA

    Li Ma, Tamer T. Onder, Scott Valastyan & Robert A. Weinberg

  3. Medical Scientist Training Program, University of Virginia, Charlottesville, 22908, Virginia, USA

    Harsha Prabhala

  4. Center for Medical Genetics, Ghent University Hospital, Ghent, 9000, Belgium

    Pieter Mestdagh, Frank Speleman & Jo Vandesompele

  5. Department of Tumor Genetics, German Cancer Center, Im Neuenheimer Feld 280, Heidelberg, 69120, Germany

    Daniel Muth & Frank Westermann

  6. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, 10021, New York, USA

    Julie Teruya-Feldstein

Authors
  1. Li Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Harsha Prabhala
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elizabeth Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pieter Mestdagh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daniel Muth
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Julie Teruya-Feldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ferenc Reinhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tamer T. Onder
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Scott Valastyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Frank Westermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Frank Speleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jo Vandesompele
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Robert A. Weinberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

L.M. conceived the project. R.A.W. supervised research. L.M. and H.P. designed experiments. L.M., J.Y., H.P., E.P., J.T.-F. and F.R. performed most of the experiments and analysed data. P.M., D.M., F.W., F.P. and J.V. contributed MYCN and ChIP-on-chip data. T.T.O. contributed some of the constructs and shared unpublished observations. S.V. modified the miRNA sponge design for stable expression. L.M. and R.A.W. wrote the manuscript.

Corresponding author

Correspondence to Robert A. Weinberg.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

Supplementary Information (PDF 844 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ma, L., Young, J., Prabhala, H. et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12, 247–256 (2010). https://doi.org/10.1038/ncb2024

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncb2024

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer